Literature DB >> 1155202

A long-term follow-up study of schizophrenia: psychiatric course of illness and prognosis.

G Huber, G Gross, R Schüttler.   

Abstract

A systematic psychiatric follow-up study of 502 schizophrenics was carried out using the same well-defined criteria to evaluate the patients throughout the investigation. After an average course of disease of 22.4 years, 22.1% of the patients showed complete psychopathological remission, 43.2% had non-characteristic types of remission and 34.7% suffered from characteristic schizophrenic deficiency syndromes. At the time of the last follow-up investigation, 86.7% of the patients were living at home, while 13.3% were permanently hospitalized. Of the entire sample, 55.9% were found to be "socially recovered". Higher education, psychoreactive provocation, depressive traits, perception of delusions, catatonic agitation, non-characteristic thought disorders and symptoms of depersonalization at the onset of the illness tended to carry with them a favorable prognosis. On the other hand, low intelligence, abnormal primary personality, premorbid disturbances in social behavior, broken homes, prolonged prodromal stages, pneumoence-phalographically measurable atrophic or dysplastic changes in the brain ventricles as well as somatic and auditory hallucinations and predominance of hebephrenic symptoms at the onset of the illness tended to lead to an unfavorable prognosis. The principle of the basic reversibility of typical schizophrenic symptoms and the extensive irreversibility of the non-characteristic defect is important for the psychopathological and social long-term prognosis.

Entities:  

Mesh:

Year:  1975        PMID: 1155202     DOI: 10.1111/j.1600-0447.1975.tb00022.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  21 in total

Review 1.  Negative symptoms: psychopathological models.

Authors:  J Ananth; A Djenderdjian; P Shamasunder; J Costa; J Herrera; J Sramek
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

Review 2.  Recovery in schizophrenia: reality or mere slogan.

Authors:  Natalie B Slopen; Patrick W Corrigan
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

Review 3.  Antipsychotic medication for elderly people with schizophrenia.

Authors:  R G Marriott; W Neil; S Waddingham
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

4.  A case of rapid conversion to psychosis of delusional misidentification associated with derealisation, verbal memory impairment and FDG-PET imaging abnormalities.

Authors:  Anna Comparelli; Georgios D Kotzalidis; Simone Di Pietro; Antonio Del Casale; Antonella De Carolis
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-05-08       Impact factor: 4.785

5.  Predictors of clinical and social outcomes after hospitalization in schizophrenia.

Authors:  P R Menezes; L C Rodrigues; A H Mann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

6.  Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.

Authors:  A Fitton; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

7.  Relapse in schizophrenia.

Authors:  J K Wing
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-02

8.  Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia.

Authors:  Mehmet Hanifi Kokaçya; Osman Virit; Ümit Sertan Çöpoğlu; Haluk Savaş; Mustafa Ari; Bülent Bahçeci
Journal:  Noro Psikiyatr Ars       Date:  2016-12-01       Impact factor: 1.339

9.  First attacks of schizophrenia.

Authors: 
Journal:  Br Med J       Date:  1977-03-19

10.  The vision of recovery today: what it is and what it means for services.

Authors:  Marianne Farkas
Journal:  World Psychiatry       Date:  2007-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.